Oncology PracticeDoubling Fulvestrant Dose Extends Breast Cancer SurvivalDecember 6, 2012Breast Cancer
Oncology PracticeLess Invasive Biopsy Used Less in Black Breast Cancer PatientsDecember 6, 2012Breast Cancer
Oncology PracticeExperimental Drug Puts ER-Positive Breast Cancer on HoldDecember 6, 2012Breast Cancer
Oncology PracticeSan Antonio Roundtable, Part 1: Fulvestrant Dose and Tamoxifen DurationDecember 5, 2012Breast Cancer
Oncology PracticeBreast Cancer: Molecular Profiling Doesn't Trump Standard PathologyDecember 5, 2012Breast Cancer
Oncology PracticeSurviving breast cancer shouldn't mean relinquishing intimacyDecember 5, 2012Breast CancerPatient & Survivor Care
Oncology PracticeRapid Feedback Boosts Adherence to Oncology Quality MeasuresDecember 4, 2012Breast CancerGastroenterologyPractice ManagementBusiness of MedicineGastrointestinal Cancer
The Journal of Community and Supportive OncologyBRCA1/2 testing and cancer risk management in underserved women at a public hospitalDecember 1, 2012Gynecologic CancerBreast Cancer
Oncology PracticePsoriasis Patients Have Low Rates of Common CancersNovember 30, 2012Breast CancerGastroenterologyGenitourinary CancerGastrointestinal Cancer
Oncology PracticeDr. C. Kent Osborne Previews the San Antonio Breast Cancer SymposiumNovember 30, 2012Breast Cancer
Oncology PracticeMore Bevacizumab Trials to Report Outcomes in San AntonioNovember 28, 2012Breast CancerRare Diseases
Oncology PracticeSan Antonio Breast Cancer Symposium: More to Come on 2011 Practice Changers November 28, 2012Breast Cancer
